[两个新生儿Legionella肺炎的病例]
Yin-Zhi Liu1, Rong Zhang1, Jing-Jing Xie1
1Department of Neonatology, Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), Changsha 410007, China.
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
|September 13, 2024
概括
下一代元基因组测序 (mNGS) 有助于诊断由莱吉欧内拉肺炎 (LP) 引起的严重新生儿肺炎. 早期诊断和使用类抗生素 (如阿兹胺素) 的治疗对于婴儿的康复至关重要.
科学领域:
- 新生儿科学 新生儿科学
- 传染性疾病 传染性疾病
- 基因组学就是基因组学.
背景情况:
- 新生儿肺炎表现为非特异性症状,使早期诊断复杂化.
- 新生儿肺炎 (LP) 是新生儿严重感染的潜在原因.
- 下一代元基因组测序 (mNGS) 为未知的感染提供了广泛的诊断方法.
研究的目的:
- 突出mNGS在诊断新生儿莱吉欧内拉肺炎感染中的实用性.
- 强调新生儿LP肺炎和败血症的临床表现和管理.
- 倡导阿齐思罗米作为新生儿LP肺炎的首选治疗方法.
主要方法:
- 两名新生儿患有严重的肺炎和败血症的病例报告.
- 在血液,支气管支气管洗液和脑脊液上利用了下一代元基因组测序 (mNGS).
- 关于呈现,诊断,治疗和结果的临床数据收集.
主要成果:
- 在这两名患者中,mNGS检测出了Legionella pneumophila,使得LP肺炎,败血症和内感染的确诊成为可能.
- 这两名婴儿都接受了宏类抗生素治疗 (erythromycin和azithromycin) 并康复.
- 第1名患者接受了红红素和亚红素;第2名患者接受了红红素.
结论:
- 新生儿LP肺炎需要高度的临床怀疑,因为非特异性症状.
- mNGS是用于快速和准确诊断未知病因的重症新生儿肺炎的宝贵工具.
- 建议阿齐思罗米作为新生儿LP肺炎的首选抗菌剂.
相关概念视频
01:30Pneumonia I: Introduction
214
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
01:30Pneumonia III: Complications and Assessment
188
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
188
01:28Pneumonia IV: Management
309
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
309